跳至主要内容
临床试验/NCT01401387
NCT01401387撤回4 期

Exocrine Pancreatic Insufficiency in Pancreatic Cancer: Evaluating the Need and Efficacy of Pancreatic Enzyme Replacement Therapy

Foundation for Liver Research2 个研究点 分布在 1 个国家开始时间: 2011年10月1日最近更新:
适应症

试验速览

阶段
4 期
状态
撤回
发起方
试验地点
2
主要终点
To evaluate if prescribing pancreatic enzymes in patients with pancreatic cancer leads to a decrease in weight loss.

研究概览

简要总结

This study will evaluate the effect of immediate pancreatic enzyme suppletion on the physical and mental health status and survival of patients who are diagnosed with pancreatic cancer and are highly likely to develop exocrine pancreatic insufficiency during their disease process.

详细描述

Weight loss in cancer is caused by primary tumour effects and secondary effects (e.g. side effects of treatment, mechanical and intestinal obstruction). In pancreatic cancer, additional weight loss and malnutrition may be due to the development of exocrine pancreatic insufficiency (EPI). The presence of EPI in pancreatic cancer is frequently overlooked, because the focus of treatment is directed at possible surgery or chemotherapy and its potential side effects. Although studies have proven that pancreatic enzymes may prevent or decrease weight loss, they are seldom being prescribed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adenocarcinoma of the pancreas (histologically confirmed)
  • Normal exocrine pancreatic function (Fecal Elastase test > 0.2 mg/g)
  • Capable and willing to follow instructions given by the physician.

排除标准

  • Other causes of fat malabsorption (celiac disease, IBD, and major gastrointestinal surgery).
  • < 18 years.

结局指标

主要结局

To evaluate if prescribing pancreatic enzymes in patients with pancreatic cancer leads to a decrease in weight loss.

时间窗: every month during 6 months after inclusion

Percentage of change in body weight ((index weight - monthly weight)/ index weight) x100% during the 6 months of follow-up. This will be measured on a monthly basis and measured by area under the ROC (Receiver Operating Characteristic) curve

次要结局

  • improvement of the nutritional status(every month during six months after inclusion)
  • quality-of-life(on a monthly base during 6 months after inclusion)

研究者

发起方
Foundation for Liver Research
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验